Navigation Links
Bhopal Gas Victims Get Spurious Drugs, Say Activists

Terming it as a 'citizens raid', Bhopal gas tragedy survivors' organisations claimed //to have seized a large number of sub-standard and expired drugs from two medical stores of the Bhopal Gas Tragedy Relief and Rehabilitation Department.

"A joint team of four organisations, working for the victims of the world's worst man-made industrial disaster, recovered many medicines that had crossed their expiry date," Rachna Dhingra of Bhopal Group of Information and Action (BGIA) said.

Addressing a press conference, she said of the 83 samples collected, more than 30 had passed their expiry date. The outdated medicines were antibiotics such as norfloxacin, ampicillin and tetracyclin.

Members of three other survivors' organisations - Bhopal Gas Peedit Mahila Stationery Karmachari Sangh (BGPMSKS), Bhopal Gas Peedit Mahila Purush Sangharsh Morcha (BGPMPSM) and Bhopal ki Awaaz (BKA) - were also present on the occasion.

"More than half of the samples collected were of medicines manufactured in Indore which is notorious for manufacturing spurious drugs," they said.

The activists alleged that despite the Supreme Court directives to send random samples of medicines for test at reputed laboratories, the state government has not taken any step in this regard.



Source-IANS
'"/>




Page: 1

Related medicine news :

1. Doctors Resign from Hospital for Bhopal Gas Victims
2. Bhopal Residents Relish Chicken despite Bird Flu Scare
3. State Govt To Provide Safe Drinking Water To Bhopal Gas Victims
4. Bhopal Archbishop’s Concern Over Maternal Mortality Rat
5. Six More Bhopal Gas Tragedy Continues to Take Toll
6. 500 People Affected by Gas Leak Near Bhopal
7. Children of Bhopal Gas Victims Suffer from Deformity
8. Funds Increased for Treating Bhopal Gas Victims
9. Bhopal Gas Victims Demand Treatment of Children With Birth Defects
10. Snail venom Found To Ease Pain In Cancer Victims
11. Patients Suffering From Severe Mental Diseases Are At Risk Of Being Crime Victims
Post Your Comments:
Breaking Medicine Technology:RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 2RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 3AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Skincare Industry Newcomer Shines 51058 1Skincare Industry Newcomer Shines 51058 2For Treatment of Dyslipidemia Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials 51055 1For Treatment of Dyslipidemia Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials 51055 2For Treatment of Dyslipidemia Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials 51055 3Allied World Schedules Second Quarter 2009 Earnings Announcement and Conference Call 51052 1